Analyst Ratings for InspireMD (NSPR)
NSPR Rating Summary
NSPR Price Target Summary
- Highest: $6.00 (Maxim Group)
- Lowest: $3.00 (Piper Sandler)
- Average: $4.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$4.33 (+510.3%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 89%
Avg. $ Target:
$4.33 (+510.3%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/2/2026 | Maxim Group | Anthony Vendetti | New Coverage | Buy (N/A) |
6.00 (N/A) |
1.58 (0.71) |
-55.06% | Details |
| 12/11/2024 | Lake Street » Updated 5/4/2026 |
Frank Takkinen | New Coverage | Buy (N/A) |
4.00 (5.00) |
3.14 (0.71) |
-77.39% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


